EMAS position statement: The ten point guide to the integral management of menopausal health

Maturitas

Volumn 81, Issue 1, 2015, Pages 88-92

  Neves E Castro, Manuel ^a   Birkhauser, Martin ^b   Samsioe, Goran ^c   Lambrinoudaki, Irene ^d   Palacios, Santiago ^e   Borrego, Rafael Sanchez ^f   Llaneza, Placido ^g   Ceausu, Iuliana ^h,i   Depypere, Herman ^j   Erel, C Tamer ^k   Pérez López, Faustino R ^l   Schenck Gustafsson, Karin ^m   Van Der Schouw, Yvonne T ⁿ   Simoncini, Tommaso ^o   Tremollieres, Florence ^p   Rees, Margaret ^q  

^a Clinica da Menopausa   (Portugal)

^b UNIVERSITY OF BERN   (Switzerland)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF ATHENS   (Greece)

^e Instituto Palacios de Salud Y Medicina de la Mujer   (Spain)

^f Diatros   (Spain)

^g HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^h CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

ⁱ CANTACUZINO INSTITUTE   (Romania)

^j GHENT UNIVERSITY HOSPITAL   (Belgium)

^k ISTANBUL UNIVERSITY   (Turkey)

^l UNIVERSITY OF ZARAGOZA   (Spain)

^m KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^o UNIVERSITY OF PISA   (Italy)

^p Paul Sabatier University   (France)

^q JOHN RADCLIFFE HOSPITAL   (United Kingdom)

more..

Author keywords

Hot flushes; Menopausal hormone therapy; Menopause; Osteoporosis; Postreproductive health; Screening

Indexed keywords

ANDROGEN; ESTROGEN; GESTAGEN; SEROTONIN UPTAKE INHIBITOR; TIBOLONE;

ANDROGEN THERAPY; ARTICLE; CLIMACTERIUM; CLINICAL ASSESSMENT; CONTRACEPTION; DIET; ESTROGEN THERAPY; FEMALE; FOLLOW UP; FORECASTING; HEALTH CARE MANAGEMENT; HEALTH CARE NEED; HEALTH PROMOTION; HOT FLUSH; HUMAN; LIFESTYLE; MEDICAL EXAMINATION; MEDICAL HISTORY; MENOPAUSAL SYNDROME; MENOPAUSE; MUSCULOSKELETAL FUNCTION; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PREMATURE OVARIAN FAILURE; SCREENING; SKELETON; UROGENITAL TRACT DISEASE; WOMEN'S HEALTH; ATROPHY; DYSPAREUNIA; DYSURIA; HOT FLASHES; OSTEOPOROSIS; PATHOLOGY; SYNDROME; VAGINA; VULVA;

ATROPHY; CONTRACEPTION; DIET; DYSPAREUNIA; DYSURIA; FEMALE; HOT FLASHES; HUMANS; LIFE STYLE; MENOPAUSE; OSTEOPOROSIS; PERIMENOPAUSE; SYNDROME; VAGINA; VULVA; WOMEN'S HEALTH;

EID: 84928087157     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.02.003     Document Type: Article

References (50)

1. B. Gjelsvik, E.O. Rosvold, J. Straand, I. Dalen, and S. Hunskaar Symptom prevalence during menopause and factors associated with symptoms and menopausal age. Results from the Norwegian Hordaland Women's Cohort study Maturitas 70 2011 383 390
2. J. Vivian-Taylor, and M. Hickey Menopause and depression: is there a link? Maturitas 79 2014 142 146
3. S.D. Harlow, M. Gass, and J.E. Hall Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging J Clin Endocrinol Metab 97 2012 1159 1168
4. D. Dewailly, C.Y. Andersen, and A. Balen The physiology and clinical utility of anti-Mullerian hormone in women Hum Reprod Update 20 2014 370 385
5. H. Depypere, J. Desreux, and F.R. Pérez-López EMAS position statement: individualized breast cancer screening versus population-based mammography screening programmes Maturitas 79 2014 481 486
6. J. Compston, C. Bowring, and A. Cooper Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 Maturitas 75 2013 392 396
7. D.C. Goff Jr., D.M. Lloyd-Jones, and G. Bennett 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 25 Suppl. 2 2014 S49 S73
8. S.D. Sullivan, C. Welt, and S. Sherman FMR1 and the continuum of primary ovarian insufficiency Semin Reprod Med 29 2011 299 307
9. E. Dreisler, L.G. Poulsen, and S.L. Antonsen EMAS clinical guide: assessment of the endometrium in peri and postmenopausal women Maturitas 75 2013 181 190
10. E. Ekelund, H.A. Ward, and T. Norat et al Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC) Am J Clin Nutr 2015 Jan 14 10.3945/ajcn.114.100065
11. S.R. Davis, C. Castelo-Branco, and P. Chedraui Understanding weight gain at menopause Climacteric 15 2012 419 429
12. I. Lambrinoudaki, I. Ceasu, and H. Depypere EMAS position statement: diet and health in midlife and beyond Maturitas 74 2013 99 104
13. Z. Li, and D. Heber Sarcopenic obesity in the elderly and strategies for weight management Nutr Rev 70 2012 57 64
14. A. Daley, H. Stokes-Lampard, and C. Macarthur Exercise for vasomotor menopausal symptoms Cochrane Database Syst Rev 5 2011 CD006108
15. L. Stojanovska, V. Apostolopoulos, R. Polman, and E. Borkoles To exercise, or, not to exercise, during menopause and beyond Maturitas 77 2014 318 323
16. A. Daley, A. Thomas, and A. Roalfe The effectiveness of exercise as treatment for vasomotor menopausal symptoms: randomised controlled trial BJOG 2014 10.1111/1471-0528.13193
17. F. Borrelli, and E. Ernst Alternative and complementary therapies for the menopause Maturitas 66 2010 333 343 10.1016/j.maturitas.2010.05.010
18. T.J. de Villiers, M.L. Gass, and C.J. Haines Global Consensus Statement on menopausal hormone therapy Maturitas 74 2013 391 392
19. S. Palacios, H. Currie, T.S. Mikkola, and E. Dragon Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide Maturitas 81 2015 92 95
20. S. Ghazal, and L. Pal Perspective on hormone therapy 10 years after the WHI Maturitas 76 2013 208 212
21. S.N. Bhupathiraju, and J.E. Manson Menopausal hormone therapy and chronic disease risk in the WHI: is timing everything? Endocr Pract 20 2014 1201 1213
22. R. Sánchez-Borrego, N. Mendoza, and E. Beltrán Position of the Spanish Menopause Society regarding the management of menopausal symptoms in breast cancer patients Maturitas 75 2013 294 300
23. D.R. Walega, L.H. Rubin, S. Banuvar, L.P. Shulman, and P.M. Maki Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women Menopause 21 2014 807 814
24. K. Wylie, M. Rees, and G. Hackett Androgens, health and sexuality in women and men Maturitas 67 3 2010 275 289 10.1016/j.maturitas.2010.07.011
25. M.E. Wierman, W. Arlt, and R. Basson Androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline J Clin Endocrinol Metab 99 10 2014 3489 3510 10.1210/jc.2014-2260
26. G.C. Kabat, V. Kamensky, and M. Heo Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women Maturitas 79 2014 70 76
27. D.J. Portman, M.L. Gass, and Vulvovaginal Atrophy Terminology Consensus Conference Panel Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society Maturitas 79 2014 349 354
28. M. Rees, F.R. Pérez-López, and I. Ceausu EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy Maturitas 73 2012 171 174
29. A. Sinha, and A.A. Ewies Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview Climacteric 16 2013 305 312
30. D. Portman, S. Palacios, R.E. Nappi, and A.O. Mueck Ospemifene, a non-estrogen selective estrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial Maturitas 78 2014 91 98
31. Senshio http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002780/smops/Positive/human-smop-000759.jsp&mid=WC0b01ac058001d127 [accessed 16.01.15]
32. E. Visser, G.H. de Bock, and E.J. Messelink Active encouragement of older women with urinaryincontinence in primary care to undergo diagnosis and treatment: a matched-pair cluster randomized controlled trial Maturitas 2014 S0378 S5122 10.1016/j.maturitas.2014.11.015
33. F.R. Pérez-López, I. Ceausu, and H. Depypere EMAS clinical guide: vulvar lichen sclerosus in peri and postmenopausal women Maturitas 74 2013 289 292
34. K.E. Poole, and J.E. Compston Bisphosphonates in the treatment of osteoporosis BMJ 344 2012 e3211 10.1136/bmj.e3211
35. J.V. Pinkerton, S. Thomas, and A.C. Dalkin Osteoporosis treatment and prevention for postmenopausal women: current and future therapeutic options Clin Obstet Gynecol 56 2013 711 721
36. J.Y. Reginster, A. Neuprez, and C. Beaudart Antiresorptive drugs beyond bisphosphonates and selective estrogen receptor modulators for the management of postmenopausal osteoporosis Drugs Aging 31 2014 413 424
37. J. Compston Strontium ranelate lives to fight another day Maturitas 78 2014 75 76
38. A.V. Uihlein, and B.Z. Leder Anabolic therapies for osteoporosis Endocrinol Metab Clin North Am 41 2012 507 525
39. V. Lim, and B.L. Clarke New therapeutic targets for osteoporosis: beyond denosumab Maturitas 73 2012 269 272
40. L. Bart Clarke anti-sclerostin antibodies: utility in treatment of osteoporosis Maturitas 78 2014 199 204
41. A.F. Ambrose, G. Paul, and J.M. Hausdorff Risk factors for falls among older adults: a review of the literature Maturitas 75 2013 51 61
42. T.J. Aspray, C. Bowring, and W. Fraser National osteoporosis society vitamin D guideline summary Age Ageing 43 2014 592 595
43. N. Mendoza, M.D. Juliá, and D. Galliano Spanish consensus on premature menopause Maturitas 2014 S0378 S5122 10.1016/j.maturitas.2014.11.007
44. L.T. Shuster, D.J. Rhodes, and B.S. Gostout Premature menopause or early menopause: long-term health consequences Maturitas 65 2010 161 166
45. M.K. Baldwin, and J.T. Jensen Contraception during the perimenopause Maturitas 76 2013 235 242
46. Faculty of Sexual and Reproductive Healthcare (FSRH) Contraception for women aged over 40 years 2010 FSRH London http://www.fsrh.org/pdfs/ContraceptionOver40July10.pdf [accessed 16.01.15]
47. J. Hugon-Rodin, A. Gompel, and G. Plu-Bureau Epidemiology of hormonal contraceptives-related venous thromboembolism Eur J Endocrinol 171 2014 R221 R230
48. B. Cartwright, D. Holloway, J. Grace, J. Robinson, and J. Rymer A service evaluation of women attending the menopause/premature ovarian failure clinic of a tertiary referral centre J Obstet Gynaecol 32 2012 357 361
49. E. Barrett-Connor, S.W. Wade, and T.P. Do Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™ Osteoporos Int 23 2012 733 741
50. F. Cosman, S.J. de Beur, and M.S. LeBoff Clinician's guide to prevention and treatment of osteoporosis Osteoporos Int 25 2014 2359 2381